Advertisement
Screener

RETRACTABLE TECHNOLOGIES INC (RVP) Debt and Equity Securities, Unrealized Gain (Loss)

1.8 / 5 stars · 43/120 Roast Me

RETRACTABLE TECHNOLOGIES INC Debt and Equity Securities, Unrealized Gain (Loss)

RETRACTABLE TECHNOLOGIES INC (RVP) reported Debt and Equity Securities, Unrealized Gain (Loss) of -$179.15 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Other Income

us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss · last filed 2026-08-14

  • RETRACTABLE TECHNOLOGIES INC debt and equity securities, unrealized gain (loss) for the quarter ending 2026-06-30 was -$179.15K, a 111.52% decline year-over-year.
  • RETRACTABLE TECHNOLOGIES INC debt and equity securities, unrealized gain (loss) for the quarter ending 2026-03-31 was $192.17K.
  • RETRACTABLE TECHNOLOGIES INC debt and equity securities, unrealized gain (loss) for the quarter ending 2025-12-31 was -$1.82M, a 119.34% decline year-over-year.
  • RETRACTABLE TECHNOLOGIES INC debt and equity securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $2.38M, a 64.42% increase year-over-year.
  • RETRACTABLE TECHNOLOGIES INC debt and equity securities, unrealized gain (loss) for fiscal 2025 was -$5.04M, a 146.60% decline from fiscal 2024.
  • RETRACTABLE TECHNOLOGIES INC debt and equity securities, unrealized gain (loss) for fiscal 2024 was $10.81M.
  • RETRACTABLE TECHNOLOGIES INC debt and equity securities, unrealized gain (loss) for fiscal 2023 was -$10.52M, a 548.98% decline from fiscal 2022.
  • RETRACTABLE TECHNOLOGIES INC debt and equity securities, unrealized gain (loss) for fiscal 2022 was $2.34M, a 356.32% increase from fiscal 2021.
Period endDebt and Equity Securities, Unrealized Gain (Loss) 3 monthDebt and Equity Securities, Unrealized Gain (Loss) 6 monthDebt and Equity Securities, Unrealized Gain (Loss) 6 month as first filedDebt and Equity Securities, Unrealized Gain (Loss) 9 monthDebt and Equity Securities, Unrealized Gain (Loss) 12 monthDebt and Equity Securities, Unrealized Gain (Loss) 12 month as first filed
2026-06-30-$179.15K
10-Q · filed 2026-08-14
$13.02K
10-Q · filed 2026-08-14
-$1.81M
derived: sum of 3 quarters · filed 2026-08-14
$577.87K
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$192.17K
10-Q · filed 2026-05-15
-$1.63M
derived: sum of 2 quarters · filed 2026-05-15
$757.02K
derived: sum of 3 quarters · filed 2026-05-15
$2.31M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31-$1.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$564.85K
derived: sum of 2 quarters · filed 2026-03-27
$2.12M
derived: sum of 3 quarters · filed 2026-08-14
-$5.04M
10-K · filed 2026-03-27
2025-09-30$2.38M
10-Q · filed 2025-11-14
$3.94M
derived: sum of 2 quarters · filed 2026-08-14
-$3.22M
10-Q · filed 2025-11-14
$6.19M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$1.56M
10-Q · filed 2026-08-14
-$5.60M
10-Q · filed 2026-08-14
$3.80M
derived: sum of 3 quarters · filed 2026-08-14
$5.25M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31-$7.16M
10-Q · filed 2026-05-15
$2.25M
derived: sum of 2 quarters · filed 2026-05-15
$3.70M
derived: sum of 3 quarters · filed 2026-05-15
$1.92M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$9.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$10.85M
derived: sum of 2 quarters · filed 2026-03-27
$9.07M
derived: sum of 3 quarters · filed 2026-03-27
$10.81M
10-K · filed 2026-03-27
2024-09-30$1.45M
10-Q · filed 2025-11-14
-$329.99K
derived: sum of 2 quarters · filed 2025-11-14
$1.40M
10-Q · filed 2025-11-14
$2.18M
derived: sum of 4 quarters · filed 2026-03-27
2024-06-30-$1.78M
10-Q · filed 2025-08-14
-$47.16K
10-Q · filed 2025-08-14
$729.88K
derived: sum of 3 quarters · filed 2026-03-27
-$5.81M
derived: sum of 4 quarters · filed 2026-03-27
2024-03-31$1.73M
10-Q · filed 2025-05-15
$2.51M
derived: sum of 2 quarters · filed 2026-03-27
-$4.03M
derived: sum of 3 quarters · filed 2026-03-27
-$10.28M
derived: sum of 4 quarters · filed 2026-03-27
2023-12-31$777.04K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$5.76M
derived: sum of 2 quarters · filed 2026-03-27
-$12.01M
derived: sum of 3 quarters · filed 2026-03-27
-$10.52M
10-K · filed 2026-03-27
2023-09-30-$6.54M
10-Q · filed 2024-11-14
-$12.79M
derived: sum of 2 quarters · filed 2024-11-14
-$11.30M
10-Q · filed 2024-11-14
-$7.77M
derived: sum of 4 quarters · filed 2025-03-28
2023-06-30-$6.25M
10-Q · filed 2024-08-14
-$4.76M
10-Q · filed 2024-08-14
-$1.23M
derived: sum of 3 quarters · filed 2025-03-28
-$1.84M
derived: sum of 4 quarters · filed 2025-03-28
2023-03-31$1.49M
10-Q · filed 2024-05-15
$5.02M
derived: sum of 2 quarters · filed 2025-03-28
$4.41M
derived: sum of 3 quarters · filed 2025-03-28
$504.26K
derived: sum of 4 quarters · filed 2025-03-28
2022-12-31$3.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28
$2.92M
derived: sum of 2 quarters · filed 2025-03-28
-$987.75K
derived: sum of 3 quarters · filed 2025-03-28
$2.34M
10-K · filed 2025-03-28
2022-09-30-$615.22K
10-Q · filed 2023-11-14
-$4.52M
derived: sum of 2 quarters · filed 2023-11-14
-$1.19M
10-Q · filed 2023-11-14
-$1.49M
derived: sum of 4 quarters · filed 2024-03-29
2022-06-30-$3.90M
10-Q · filed 2023-08-14
-$572.41K
10-Q · filed 2023-08-14
-$572.00K
10-Q · filed 2022-08-15
-$875.03K
derived: sum of 3 quarters · filed 2024-03-29
-$1.66M
derived: sum of 4 quarters · filed 2024-03-29
2022-03-31$3.33M
10-Q · filed 2023-05-15
$3.03M
derived: sum of 2 quarters · filed 2024-03-29
$2.24M
derived: sum of 3 quarters · filed 2024-03-29
$2.74M
derived: sum of 4 quarters · filed 2024-03-29
2021-12-31-$302.62K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
-$1.09M
derived: sum of 2 quarters · filed 2024-03-29
-$590.44K
derived: sum of 3 quarters · filed 2024-03-29
$513.53K
10-K · filed 2024-03-29
$2.52M
10-K · filed 2022-03-31
2021-09-30-$783.85K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
-$287.82K
derived: sum of 2 quarters · filed 2022-08-15
$816.15K
10-Q · filed 2021-11-15
$2.13M
derived: sum of 4 quarters · filed 2023-03-30
2021-06-30$496.03K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$1.60M
10-Q · filed 2022-08-15
$1.58M
10-Q · filed 2021-08-16
$2.91M
derived: sum of 3 quarters · filed 2023-03-30
$2.60M
derived: sum of 4 quarters · filed 2023-03-30
2021-03-31$1.10M
10-Q · filed 2022-05-16
$2.41M
derived: sum of 2 quarters · filed 2023-03-30
$2.10M
derived: sum of 3 quarters · filed 2023-03-30
$3.14M
derived: sum of 4 quarters · filed 2023-03-30
2020-12-31$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$999.25K
derived: sum of 2 quarters · filed 2023-03-30
$2.03M
derived: sum of 3 quarters · filed 2023-03-30
$1.87M
10-K · filed 2023-03-30
$2.00M
10-K · filed 2022-03-31
2020-09-30-$311.22K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$723.88K
derived: sum of 2 quarters · filed 2021-11-15
$559.54K
10-Q · filed 2021-11-15
2020-06-30$1.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
$870.76K
10-Q · filed 2021-08-16
2020-03-31-$164.34K
10-Q · filed 2021-05-17
2019-09-30$27.60K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
$86.63K
derived: sum of 2 quarters · filed 2020-11-16
$129.73K
10-Q · filed 2020-11-16
2019-06-30$59.03K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$102.13K
10-Q · filed 2020-08-14
2019-03-31$43.10K
10-Q · filed 2020-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
FEMASYS INC (FEMY)United States$0.020B-1.07
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
ACCURAY INC (ARAY)United States$0.027B-0.63
Glucotrack, Inc. (GCTK)United States$0.027B
CERENOME, INC. (CNSY)United States$0.014B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
Picard Medical, Inc. (PMI)United States$0.011B-0.01